IN Capital
约印医疗基金
IN CapitalFund
约印医疗基金
渲染中…
Mentioned in 3 articles
Coverage
ImmuPharm Raises Nearly RMB 200 Million in Pre-IPO Round Co-Led by Gaorong Ventures, Building Dual Engine in Solid Tumors and In Vivo CAR-T
Bringing long-term survival benefits to cancer patients worldwide.
高榕创投·Medical Device/Chip Companies Close New Funding Rounds, Driving High-Quality Growth Through R&D, Commercialization, and Supply Chain | Rong Report · February
Infinite possibilities for creating a better life.
高榕创投·Haijieya Completes New Funding Round to Build Integrated Platform for Interventional Oncology Treatment
Providing a comprehensive suite of minimally invasive interventional diagnosis and treatment solutions for oncology.
高榕创投·
